Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of an artificial intelligence-driven triage system on workflow and transfer efficiency: stratified analysis of 4548 admissions to four thrombectomy hubs receiving transfers from sixty spokes.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Prehospital Trauma Labeling Delays Acute Stroke Reperfusion: A Matched-Pair Analysis.

Stroke·2026
Same author

Clinical Outcomes in Basal Ganglia Strokes Treated With Mechanical Thrombectomy.

Stroke (Hoboken, N.J.)·2026
Same author

Infarct Patterns in Patients With Symptomatic Carotid Webs.

Stroke (Hoboken, N.J.)·2026
Same author

Patterns of Emergency Medical Transport for Suspected Acute Stroke, Acute Myocardial Infarction, and Other Diagnoses During the COVID-19 Pandemic: A Retrospective Analysis of a Large Hospital-Based Emergency Medical Services Agency.

Stroke (Hoboken, N.J.)·2026
Same author

SVINnovation Challenge: Fostering Innovation in Vascular and Interventional Neurology.

Stroke (Hoboken, N.J.)·2026

Related Experiment Video

Updated: Jun 20, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

14.8K

Secondary Risk Reduction after Transient Ischemic Attack and Minor Stroke.

Mohammad J Ahmad1, Nirav R Bhatt2

  • 1Cerebrovascular Institute, Cleveland Clinic Foundation, Cerebrovascular Center, 9500 Euclid Avenue, S80, Cleveland, OH 44195, USA. Electronic address: https://twitter.com/MoeJAhmad.

The Medical Clinics of North America
|February 1, 2025
PubMed
Summary

Transient ischemic attack (TIA) and minor stroke share risk factors and management strategies. Early identification, workup, and antithrombotic therapy are crucial for effective treatment and risk factor control.

Keywords:
Antithrombotic therapyMinor strokeSecondary stroke preventionTIAVascular risk factors

More Related Videos

Induction of Ischemic Stroke and Ischemia-reperfusion in Mice Using the Middle Artery Occlusion Technique and Visualization of Infarct Area
09:08

Induction of Ischemic Stroke and Ischemia-reperfusion in Mice Using the Middle Artery Occlusion Technique and Visualization of Infarct Area

Published on: February 2, 2017

16.2K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

11.9K

Related Experiment Videos

Last Updated: Jun 20, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

14.8K
Induction of Ischemic Stroke and Ischemia-reperfusion in Mice Using the Middle Artery Occlusion Technique and Visualization of Infarct Area
09:08

Induction of Ischemic Stroke and Ischemia-reperfusion in Mice Using the Middle Artery Occlusion Technique and Visualization of Infarct Area

Published on: February 2, 2017

16.2K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

11.9K

Area of Science:

  • Neurology
  • Cerebrovascular Diseases
  • Public Health

Background:

  • Transient ischemic attack (TIA) and minor stroke definitions are evolving.
  • These conditions share significant risk factors and require similar early management approaches.

Purpose of the Study:

  • To discuss the evolving definitions of TIA and minor stroke.
  • To highlight shared risk factors and similarities in early management.
  • To review effective early antithrombotic therapies and risk factor control strategies.

Main Methods:

  • Literature review of current definitions and management guidelines.
  • Analysis of shared risk factors and early treatment modalities.
  • Discussion of evidence-based antithrombotic therapies.

Main Results:

  • Shared risk factors include hypertension, diabetes, hyperlipidemia, and atrial fibrillation.
  • Early identification and basic workup are critical for timely intervention.
  • Effective early antithrombotic therapies include aspirin and other antiplatelet agents.

Conclusions:

  • Unified approach to TIA and minor stroke management is recommended.
  • Aggressive risk factor control is essential for secondary prevention.
  • Treatment strategies should be tailored to specific stroke etiologies.